XML 89 R28.htm IDEA: XBRL DOCUMENT v3.24.3
SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
shares
$ / shares
Sep. 30, 2024
shares
$ / shares
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2023
shares
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [abstract]        
Number of stock options, beginning balance 1,422,887 1,422,887 753,337 753,337
Weighted Average Exercise Price, beginning balance | (per share) $ 4.78 $ 6.33 $ 6.13 $ 7.93
Number of stock options, Options cancelled 552,000 [1] 552,000 [1] 694,100 [2],[3],[4],[5] 694,100 [2],[3],[4],[5]
Weighted Average Exercise Price, options granted | $ / shares [2],[3],[4],[5]      
Number of stock options, Exercise of options    
Number of stock options, Expiry of options     (24,550) (24,550)
Number of stock options, Options cancelled (133,550) (133,550)    
Weighted Average Exercise Price, Options cancelled | $ / shares      
Number of stock options, ending balance 1,841,337 1,841,337 1,422,887 1,422,887
Weighted Average Exercise Price, ending balance | (per share) $ 3.86 $ 5.22 $ 4.78 $ 6.33
[1] On August 14, 2024, 552,000 stock options were issued to employees, consultants and officers with an exercise price of $1.78. The options expire on August 13, 2029. The fair value of the options granted was estimated at $779 using the Black-Scholes option pricing model, using the following assumptions: Share Price: $1.78; Expected option life 5 years; Volatility 109%; Risk-free interest rate 3.67%; Dividend yield 0%.
[2] On April 18, 2023, 169,500 stock options were issued to employees with an exercise price of CAD$4.00. The options expire on April 18, 2033. The fair value of the options granted was estimated at $420 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$3.55; Expected option life 10 years; Volatility 111%; Risk-free interest rate 3.57%; Dividend yield 0%.
[3] On February 8, 2023, 40,000 stock options were issued to a consultant with an exercise price of CAD$3.75. The options expire on November 25, 2027. The fair value of the options granted was estimated at $135 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$5.45; Expected option life 4.8 years; Volatility 112%; Risk-free interest rate 3.16%; Dividend yield 0%.
[4] On January 4, 2023, 326,600 stock options were issued to directors and consultants with an exercise price of CAD$4.125. The options expire on January 4, 2033. The fair value of the options granted was estimated at $1,017 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$4.50; Expected option life 10 years; Volatility 112%; Risk-free interest rate 3.28%; Dividend yield 0%.
[5] On June 28, 2023, 98,000 stock options were issued to officers with an exercise price of CAD$6.125. The options expire on June 28, 2033. The fair value of the options granted was estimated at $443 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$7.30; Expected option life 5 years; Volatility 111%; Risk-free interest rate 4.14%; Dividend yield 0%.